Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Carbapenem

    INTERMEDIATES

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Venus Remedies receives Ukrainian GMP approval for Its parenteral facilities
    Venus Remedies receives Ukrainian GMP approval for Its parenteral facilities

    08 Jun 2023

    // INDIAN PHARMA POST

    https://www.indianpharmapost.com/news/venus-remedies-receives-ukrainian-gmp-approval-for-its-carbapenem-oncology-parenteral-facilities-14238

    INDIAN PHARMA POST
    08 Jun 2023
    Share Share
    Venus Remedies gets good manufacturing certification from Saudi drug regulator
    Venus Remedies gets good manufacturing certification from Saudi drug regulator

    27 Feb 2023

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/venus-remedies-gets-good-manufacturing-certification-from-saudi-drug-regulator/articleshow/98267076.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    27 Feb 2023
    Share Share
    Venatorx, Roche Collaborate to Develop New Class of Antibiotics
    Venatorx, Roche Collaborate to Develop New Class of Antibiotics

    01 Nov 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211101005111/en

    BUSINESSWIRE
    01 Nov 2021
    Share Share
    Shionogi's APEKS-NP phase III trial of cefiderocol in patients
    Shionogi's APEKS-NP phase III trial of cefiderocol in patients

    05 Oct 2019

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=118558&sid=2

    PHARMABIZ
    05 Oct 2019
    Share Share
    Shionogi to Present Data on Cefiderocol and Baloxavir Marboxil
    Shionogi to Present Data on Cefiderocol and Baloxavir Marboxil

    27 Sep 2018

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20180927005497/en

    BUSINESSWIRE
    27 Sep 2018
    Share Share
    AstraZeneca spinout Entasis files for $86M IPO to fund antibiotic phase 3
    AstraZeneca spinout Entasis files for $86M IPO to fund antibiotic phase 3

    20 Aug 2018

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/astrazeneca-spinout-entasis-files-for-86m-ipo-to-fund-antibiotic-phase-3

    Nick Paul Taylor FIERCE BIOTECH
    20 Aug 2018
    Share Share